Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sales in EU, AI expansion, Walmart healthcare
This is good entry at this market cap, even if just for a flip up to .10+
News out: Collaboration with Next Realm AI
MetAlert’s AI Endeavor: Buzz or the Next Big Leap in Predictive Healthcare? (MLRT) https://pubcoinsight.com/metalerts-ai-endeavor-buzz-or-the-next-big-leap-in-predictive-healthcare/
MLRT own ChatGPT with IBM!!
Excited to explore how we can integrate #IBM generative AI through #WatsonX into MetAlert $MLRT AI strategy around wearable health data.
— Tom Bustamante (@techwizardtom) August 22, 2023
Their own private version of #ChatGPT
Big upside for shareholders at this level#GenerativeAI #ChatGPT pic.twitter.com/yuihFsISGN
Ask super thin to .10
Market makers putting very tiny offers on ask so anyone placing a limit order with all or none won't execute.
Removing all or none will show your order, and probably spook any market makers short the stock.
AI healthcare big risk for anyone short
AI in healthcare analytics is the next big wave, and any market maker shorting this is taking a big risk here.
Could see number of big players look to purchase or lease MLRT data for AI model training, or they can just keep in-house to develop their own AI powered solutions.
More data they generate data more valuable this becomes
Their growing data is valuable to big tech!
$MLRT data will become their big asset, not so much their products
— AI Venturetech (@aiventuretech) August 21, 2023
Larger #AI firms will seek to purchase their data for #AI doesn't work without #data
Been Watching for years.
🚀 Is MetAlert set to be the next AI giant in the stock arena? Marrying healthcare wearables with AI could be a game-changer!? Details here: https://finance.yahoo.com/news/metalert-embarks-strategic-integration-ai-121200642.html - Watch closely, this might just be the next big play! 🔍 #MetAlert #AIInnovation #StockWatch
NEWS: MLRT goes all in on AI
LOS ANGELES, CALIFORNIA, Aug. 21, 2023 (GLOBE NEWSWIRE) -- MetAlert, Inc. (OTC: MLRT), a pioneer in location sensitive health monitoring devices and wearable technology healthcare solutions, today announced its visionary advance into AI-driven healthcare. Initiating a series of RFPs and detailed discussions with potential developers and strategic partners, the Company is signaling its vision to incorporate groundbreaking capabilities of artificial intelligence into its various technology platforms, marking this a critical pivot for the wearable healthcare sector, and commitment to fully harness the potential of artificial intelligence to help shape the future of healthcare.
https://finance.yahoo.com/news/metalert-embarks-strategic-integration-ai-121200642.html
Yup
Show me the 10Q...
Notice of a late filing for 10Q
Show me he 10Q.
Show me the money!
Good news!!!
Start of revenue upswing?
Global Safe Tracks, its OEM manufacturer, has received its first production run and started shipping units into Germany and the U.K. Based on the initial positive feedback and forecast, an additional 1,000 devices are going into production.
.........start to see revenue points going up on the board now!
$2 mill market cap cheap for healthcare wearable device company making sales into Europe now
NEWS: MLRT begins shipping into Europe
Metalert OEM Manufacturer Begins Shipping into Germany and the U.K. and Increases Production
LOS ANGELES, CALIFORNIA, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Metalert, Inc. (OTC: MLRT) (“the Company”), a pioneer in location sensitive health monitoring devices and wearable technology products announced today Global Safe Tracks, its OEM manufacturer, has received its first production run and started shipping units into Germany and the U.K. Based on the initial positive feedback and forecast, an additional 1,000 devices are going into production. Global Safe Tracks is under license to manufacture a modified version of the GPS SmartSole that includes 2G technology as a fall back to 4G technology for countries where 4G coverage has not been fully implemented. The European version is sold under the brand name “SafeSole” and the made in U.S.A. Cat M1 Bluetooth / Wi-Fi version is sold under the brand name “GPS SmartSole plus.”
“We are very pleased with the initial manufacturing results, and the ability for more product to quickly go into production in order to meet our global demand,” stated Andrew Duncan MetAlert director.
“Since announcing our manufacturing partnership last week, we have seen immediate benefits across the supply chain. By having an extra factory and point of distribution in Germany we were able to fill orders for the U.K. within days, saving time and freight costs, back orders from Germany were quickly filled, saving time and costs, which then prompted an additional 1,000 units to go into production, as customer were seeing the improvements in our ability to ship orders. During the same time frame, we received a shipment from our U.S. factory and orders were immediately shipped out to our U.S. customers,” stated Patrick Bertagna MetAlert CEO.
Under the 3-year OEM license agreement, Global Safe Tracks will be manufacturing the SafeSole in Germany, enabling a faster on demand delivery throughout Europe, while significantly reducing tariff and shipping costs across Europe, in addition to opening up new markets where 4G is currently unavailable.
https://finance.yahoo.com/news/metalert-oem-manufacturer-begins-shipping-121200132.html
None whatsoever....
Any idea about the reason behind?
3-year license agreement with Global Safe Tracks
“Under the 3-year license agreement Global Safe Tracks will be manufacturing the SafeSole in Germany enabling a faster on demand delivery throughout Europe, while significantly reducing tariff and shipping costs across Europe, in addition to opening up new markets where 4G is currently unavailable. This agreement will expand our production capacity, reduce delivery time and costs for our European customers, and will provide us with sourcing and manufacturing redundancies. Now both companies and all our customers will have access to another manufacturing source and be able to tap into that inventory,”
NEWS: OEM agreement in Germany
https://www.otcmarkets.com/stock/MLRT/news/story?e&id=2592715
Metalert Signs Licensing and OEM Agreement with German Manufacturer
LOS ANGELES, CALIFORNIA, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Metalert, Inc. (OTC: MLRT) (“the Company”), a pioneer in location sensitive health monitoring devices and wearable technology products announced today it has entered into an OEM licensing agreement with Global Safe Tracks, a German based IT/GPS tracking company, to manufacture and distribute its GPS SmartSole technology in Europe. Global Safe Tracks under license will manufacture a modified version of the GPS SmartSole that includes 2G technology as a fall back to 4G technology for use where 4G coverage has not been fully built out in some European countries. The European version shall be marketed and distributed under the brand name of “SafeSole” however Global Safe Tracks will also continue to market and distribute the 4G Cat M1 GPS SmartSole plus version made in the U.S.
As part of the agreement, Metalert shall also have the rights to distribute the OEM 4G/2G version under the GPS SmartSole trademark for its own distribution purposes across other countries that still do not have a fully robust 4G infrastructure.
This licensing OEM agreement is part of the ongoing successful intellectual property licensing program that has generated the Company close to $1.4 Million in licensing revenues to date and builds upon the recent announcement of a new patent allowance issued by the European Patent Office for the GPS SmartSole.
“We are excited to enter into this new agreement with Global Safe Tracks who have been a long-term distribution partner of our GPS SmartSoles in Germany. The agreement is part of our strategy to increase our production capacity and ramp up sales and distribution on a global basis,” said Andrew Duncan Metalert Director. “We expect to continue to leverage our intellectual property in the growing $270 million “Smart Shoe” market and explore other OEM and licensing opportunities as we continue to roll out our SmartSole line of wearable technology.”
“We believe that the time is right to expand our partnership and fulfill the huge pent-up demand for this life changing technology for the 15 million people in Europe afflicted by Cognitive Disorders. By offering our customers the choice of these two products, we can now bring a safe, reliable service anywhere in Europe in a cost-effective manner,” said Markus Schlittenbauer, CEO of GlobalSafeTracks.
“Under the 3-year license agreement Global Safe Tracks will be manufacturing the SafeSole in Germany enabling a faster on demand delivery throughout Europe, while significantly reducing tariff and shipping costs across Europe, in addition to opening up new markets where 4G is currently unavailable. This agreement will expand our production capacity, reduce delivery time and costs for our European customers, and will provide us with sourcing and manufacturing redundancies. Now both companies and all our customers will have access to another manufacturing source and be able to tap into that inventory,” stated Patrick Bertagna MetAlert CEO.
To find out more how you can buy or become an authorized reseller or OEM contact info@metalert.com business development.
On smart shoe patents
If any big players, like Nike or Addis trys to jump into making their shoes smart with step tracking or such MLRT could be patent play for even small royalties could mean big bucks.
Nike, or some other large player, could just buy the patents off MLRT
MLRT could offer their own AirTags
Their NFC buttons are exactly like Apple AirTags, which are wildly popular.
Tag to your luggage, vehicle, keys!
https://metalert.com/nfc/
Maybe but that question should be send to the company…
So does Nike has a license from MLRT for smart soles?
Wide spread signals MM short
Market makers dropped bid to open spread up, which si sometimes indicative of MM short and trying to cover before it takes off.
https://www.otcmarkets.com/stock/MLRT/overview
MLRT holds lot of patents on Smart Shoes
As this market grows, and bigger players look to jump in, they may have to pay MLRT royalties for they will hold the patents to many of the technology in this market.
Smart Shoes Market $2.11B by 2033
Consumers’ shift towards a healthy lifestyle in the United Kingdom is predicted to boost demand for smart shoes.
Rockville, July 20, 2023 (GLOBE NEWSWIRE) -- As per a new research report by Fact.MR, a provider of market research and competitive intelligence, the Smart Shoes Market stands at US$ 270 million in 2023. Worldwide demand for smart shoes is projected to rise at an exceptionally high CAGR of 22.8% through 2033. Surging sales of smart shoes are attributed to their rapidly growing use in sports and fitness activities.
Nike, in September 2021, launched smart shoes with a theme of Oklahoma Sooners. These shoes feature better body balancing and lightweight capabilities.
The smart shoes sector is expected to grow due to the development of footwear that caters to the needs of older individuals and those focused on maintaining their health. Furthermore, the rising research and development efforts aimed at technological enhancements, such as incorporating sensors with alert capabilities for speed regulation and obstacle detection, are anticipated to drive the demand for smart shoes.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8717
Smart shoes, although resembling regular footwear, have special features that work in conjunction with users' smartphones. They are insole devices equipped with sensors that enable various functionalities such as navigation, receiving vibrations, calculating calorie burn and steps, and more. By connecting smart shoes to their smartphones via Bluetooth, users can access information about their engagement in different physical activities.
Key Takeaways from Market Study
The global smart shoes market is valued at US$ 270 million in 2023.
Worldwide demand for smart shoes is predicted to increase at a CAGR of 22.8% from 2023 to 2033.
The market is set to reach a valuation of US$ 2.11 billion by the end of 2033.
The adults segment is projected to expand at a CAGR of 20% through 2033.
Sales of smart shoes in the United States are forecasted to reach US$ 597 million by 2033-end.
Demand for step-counting shoes is set to accelerate at 22.9% CAGR through 2033.
The Indian market is forecasted to expand at a CAGR of 28.3% and reach US$ 202 million by 2033.
The smart shoes market in China is estimated to reach US$ 697 million by the end of 2033.
NEWS OUT!
https://www.otcmarkets.com/stock/MLRT/news/story?e&id=2587353
MetAlert Increases Value of its IP Portfolio by Receiving Notice of Allowance from EPO for New GPS SmartSole Patent
LOS ANGELES, CALIFORNIA, July 26, 2023 (GLOBE NEWSWIRE) -- MetAlert, Inc. (OTC: MLRT), a pioneer in location sensitive health monitoring devices and wearable technology products announced it has received a notice of allowance for a new patent by the European Patent Office (EPO). This will be the company’s first European utility patent in the GPS SmartSole family and will cover various ways to design, protect and manufacture a GPS, Cellular, Bluetooth and Wi-Fi monitoring electronic device embedded inside an insole including the inductive charging unit. This is the fifth patent granted to Metalert around tracking and monitoring devices within footwear with particular protection on the insole format.
“We have been working on this European patent for several years and we were very pleased to hear the news about the patent allowance. The timing could not have been better as we continue to roll out new generation GPS SmartSole products across Europe and North America. This new patent will provide us additional intellectual property protection in the major Western markets as well as key markets in Japan, S Korea, Australia, and New Zealand.” said Andrew Duncan Metalert Director.
“The patent has a large number of claims, with the opportunity to file additional divisional patents in the future and offers us protection against competition as well as possibly opening up new, oftentimes lucrative, licensing and partnership opportunities. While our ongoing investment in IP demonstrates MetAlert’s commitment to enhance our competitive barriers in the market, it also helps strengthen our overall value in the wearable tech industry,” stated Patrick Bertagna MetAlert CEO.
To find out more how you can buy or become an authorized reseller contact info@metalert.com business development.
Social Media:
FB: https://www.facebook.com/metalertinc
IG: https://www.instagram.com/metalert/?hl=en
Twitter: https://twitter.com/metalertinc
Linked In: https://www.linkedin.com/company/metalertinc/
YouTube: https://www.youtube.com/channel/UCUlYP1WQoLdKkDzwhGkx40Q
General information, investor relations, wholesale licensing, consumer purchase:
Tel: 213.489.3019 Email: info@metalert.com or ir@metalert.com website www.metalert.com
MetAlert
United Kingdom, London
Nelson Skip Riddle
Tel: +44 7785 364100
Email: nsriddle@metalert.com
About MetAlert, Inc.:
MetAlert (OTC: MLRT) and its subsidiaries are engaged in designing, developing, manufacturing, distributing, selling, and licensing products, services, and intellectual property in the GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. With over 20 years of experience and an extensive patent portfolio, MetAlert is a leading solution provider for consumers/patients afflicted with Alzheimer, dementia, and autism. This market represents approximately 2.9% of the world’s population. The company offers global end-to-end hardware, software, and connectivity solutions, in addition to developing two-way tracking technologies, which seamlessly integrate with consumer products, enterprise and government agency applications. Utilizing the latest in miniaturized, low power consumption GPS, Cellular, RF, NFC, and BLE technologies, enabling caregivers to track and monitor patients in real time. Known for its game-changing and award-winning patented GPS SmartSole® -- think Dr. Scholl’s meets LoJack, the world’s first invisible wearable technology tracking device created for those at risk of wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. MetAlert’s subscription-based business model is built around technology innovation with intellectual property protection. The company has international distributors servicing customers across the globe with subscribers in over 40 countries and is a U.S. Military Government contractor. Other customers include public health authorities, municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes, and consumers. www.MetAlert.com
Forward-Looking Statements
This news release contains forward-looking statements. The terms and phrases “expects,” “would,” “will,” “believes,” and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements are based on estimates and assumptions made by MetAlert considering its experience and perception of current conditions and expected future developments, as well as other factors that MetAlert believes are appropriate in the circumstances. Many factors could cause MetAlert’s actual results, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements. Certain risk factors that may cause actual results to differ are outlined in MetAlert’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (which may be obtained on the SEC Website). These factors should be considered carefully, and readers should not rely on MetAlert’s forward-looking statements. MetAlert has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required.
Be nice to see what you said come true soon.
Market cap only $2M, no toxic debt
Value is super cheap here at only around $2 million.
- SmartSole's for Alzheimer's
- Telehealth with Walmart
- AI healthcare analytics
No toxic notes for dilution
When compared to some other stocks out there no reason this can't be trading at $10M market cap, or like .50+
https://www.otcmarkets.com/stock/MLRT/security
More from PubCo Insight -
MetAlert, A Healthtech Trailblazer using AI to Revolutionize Remote Patient Monitoring – because Knowledge is Health
https://pubcoinsight.com/metalert-a-healthtech-trailblazer-using-ai-to-revolutionize-remote-patient-monitoring-because-knowledge-is-health/
As healthcare continues its digital transformation, MetAlert, Inc. (OTC: MLRT) stands out as a pioneering force in the health tech sector, making strides in location-sensitive health monitoring devices and wearable technology. This innovative company has laid out a clear strategy to expand and strengthen its position in the industry, making it a promising contender to keep an eye on in the foreseeable future.
Recently, MetAlert signed a significant agreement with HandsFree Health, the creator of the premier voice-enabled virtual health AI assistant platform, WellBe®. Through this collaboration, they plan to offer the HFH Go Digital Health Tool, an ingenious mobile health solution designed to improve healthcare management and compliance.
This partnership launched early enrollment for the HFH virtual healthcare assistant app and the MetAlert portal on July 1, 2023. The revolutionary service promises virtual urgent care to individuals, enabling them to reach a medical provider within minutes via phone, chat, or webcam, eliminating the need for physical visits. This patient-centric approach addresses the pressing need for immediate medical attention, especially in times of a healthcare crisis.
MetAlert’s extensive portfolio comprises cutting-edge products like the GPS SmartSole Plus and the 3D infrared RoomMate for indoor remote patient monitoring. With the added telehealth urgent care and WellBe AI smart health assistant, MetAlert is consolidating a vast range of data collection wearable devices, wander assistance with real-time recovery, fall prevention, remote urgent care, and symptom and treatment assistance all under one platform. This holistic approach propels the company into an advantageous position for future growth.
This integrative approach underlines MetAlert’s 360-degree growth strategy. Their plans to provide additional subscription services for comprehensive remote patient monitoring and long-term predictive analytics hint at the ambition to acquire a larger share of the market.
MetAlert’s innovative wearable technology holds massive potential in a growing market. As remote healthcare becomes a mainstay, MetAlert’s GPS SmartSole, a wearable tracking device for those at risk of wandering due to Alzheimer’s, dementia, autism, and traumatic brain injuries, can fill a critical gap in patient care.
The company’s growth strategy also extends to strategic acquisitions. MetAlert is known for its keen eye for value-adding assets, both in terms of technology and market presence. These acquisition plans may well position MetAlert as a formidable leader in the HealthTech industry.
The hands-free health client acquisition is a key example of the company’s growth strategy, integrating intelligent designs for health and wellness. This allows MetAlert to keep consumers on track to good health while significantly expanding its customer base. As Dan Messina, President and Co-founder of HandsFree Health puts it, the pairing of the HFH Go App with a nationwide Virtual Urgent Care Telehealth service is indeed a winning combination.
MetAlert’s forward-thinking approach, robust product line, and proactive acquisition plans position it as a major player to watch in the HealthTech sector. By leveraging technology for better patient outcomes, MetAlert stands poised to redefine the future of remote patient monitoring and healthcare management. All eyes are now on MetAlert as it continues to disrupt the industry with its innovative solutions. With its strong growth potential and unwavering commitment to advancing healthcare, MetAlert is undeniably a trailblazer in the industry
*LEGAL DISCLAIMER
Sounds interesting, a business plan with revenue estimates would be helpful for valuation.
AI healthcare solutions with IBM
This would turbo charge this stock up for hot sector now
Next Realm AI, an #IBM Business Partner, will help advise and collaborate with MetAlert $MLRT on developing AI solutions for the healthcare market.#healthcare #analytics #ArtificialIntelligence #stockstowatch #nextrealmaihttps://t.co/71O05Vblvr
— AI Venturetech (@aiventuretech) July 17, 2023
Voice Technology in Health Care
HandsFree Health is the creator of WellBe®, the premier voice-enabled virtual health assistant platform. With more than 150 years of combined experience in health care, our founding team sought to create a better way for people to manage their health. Our founders knew all too well the challenges that the current health care system presents for all types of people and businesses, including Caretakers, Seniors, Employers, Senior Communities, and Health Plans.
The solution : HandsFree Health—a company swiftly becoming the benchmark for voice technology in health care and medical alert companies.
https://handsfreehealth.com/
Healthcare AI + Walmart...
This could catch fire here once it breaks above .15
Looking Good for future growth.
Word gets around...
https://metalert.com/pubco-insight-riding-the-cutting-edge-why-metalert-deserves-your-attention/
June 27, 2023
The wheel of innovation grinds inexorably onward, often leaving even the most clued-in among us staggering in its wake. Navigating the ever-evolving landscape of healthcare technology, one can hardly overlook the emerging star that is MetAlert, Inc. (OTC: MLRT). This Los Angeles-based pioneer in location-sensitive health monitoring and wearable technology is pushing the boundaries of remote patient monitoring, taking the fight against time and distance to the next level.
Their latest coup? A partnership with HandsFree Health, aiming to leverage their AI-driven HFH Go Digital Health Tool. Imagine a world where you could access nationwide urgent care telehealth services right from your mobile device. With MetAlert’s initiative, this isn’t just a possibility—it’s a reality in the making.
Starting July 1, 2023, early enrollment begins via the HFH virtual healthcare assistant app and the MetAlert portal. This ingenious service positions a medical concierge and virtual urgent care at your fingertips, promising access to medical providers through phone, chat, or webcam within a matter of minutes. No more waiting rooms, no more lengthy queues—simply swift, efficient healthcare from the comfort of your own home.
MetAlert’s game-changing innovation is particularly powerful for monitoring health indicators like blood pressure, glucose, heart rate, and temperature. Moreover, the tools for charting progress, setting appointments and reminders, and searching for providers can redefine the entire healthcare experience. Imagine the impact on a nation struggling with escalating healthcare costs and access issues.
The AI-powered smart health assistant, WellBe®, is HIPAA-compliant and designed to keep seniors, caregivers, families, and businesses connected to their health and wellness. The implications of such a platform in our aging society are immense, transforming healthcare from a reactive model to a proactive, personalized system.
MetAlert’s CEO, Patrick Bertagna, refers to their comprehensive approach as a “360-degree” initiative, offering subscription services that include predictive analytics and an array of data collection wearable devices under one platform. And the accessibility? Promised at your convenience through easy monthly payments.
The potential impact of MetAlert’s venture extends even further, reaching into the lives of those affected by Alzheimer’s, dementia, and autism—approximately 2.9% of the world’s population. With patented technology like GPS SmartSole®, MetAlert is moving beyond the realm of conventional healthcare, transforming how we care for the most vulnerable among us.
The success of a company such as MetAlert lies in its potential to influence and redefine the future of healthcare, and it’s clear they have the vision, capability, and drive to do just that. They are daring to imagine a different world, a world where healthcare is seamless, personal, and connected.
As a discerning investor, you’re not one to make rash decisions. But in the case of MetAlert, you may want to keep a close eye.
Stocks ebb and flow; that’s their nature. But when you see a company that promises to harness the transformative power of technology for the betterment of healthcare – you don’t just watch, you zoom in. Let’s just say that the world is full of potentials, but only a few dare to reach for them.
Consider this a gentle nudge to perhaps pay closer attention to MetAlert and what could be a breakthrough in the urgent care landscape. After all, your portfolio is only as future-proof as the visionaries you choose to support.
It’s up to you. Make your decisions wisely.
For more information on MetAlert, their early enrollment and their breakthrough vision, visit https://metalert.com/hands-free-tele-health/
While I must remind you that every investment carries risk, … and forward-looking statements are exactly that—forward-looking. They involve future developments and other factors that MetAlert believes are appropriate in the circumstances. These should be taken into account along with MetAlert’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission.
But let’s put this in perspective. Innovation is the lifeblood of progress, and MetAlert is standing at the frontier of it. Whether it’s their revolutionary remote patient monitoring or the integration of AI technology with the healthcare landscape, the company seems to be on an unstoppable trajectory.
Taking an in-depth look at their portfolio, one can see a dazzling array of cutting-edge solutions, from the game-changing GPS SmartSole to the 3D infrared RoomMate for indoor remote patient monitoring. With such a richly diversified line of products and services, it’s hard to ignore the potentially game-changing potential of MetAlert’s proposition.
In a world that’s evolving at an unprecedented pace, those who can harness the power of technology to drive transformative change are the ones most likely to be standing when the dust settles. In the domain of healthcare—a sector already teeming with complexity and crying out for innovative solutions—MetAlert is emerging as a trailblazer.
Yes, as seasoned investors, we understand the nuances of the market. We know that the numbers don’t always tell the whole story. We know that past performance is no guarantee of future results. But sometimes, it’s not just about what the figures say. It’s about what the vision inspires, what the innovation promises, and what the dedication delivers.
So, while I’m not in the business of telling you what to do with your investment dollars, I would suggest that MetAlert, Inc. is worth watching. The company is clearly pushing boundaries, and in an industry that’s ripe for disruption, such audacity and innovation could prove more than just worthwhile.
As always, it’s your call. But as we stand at the threshold of a new era in healthcare technology, MetAlert just might be one of those companies worth keeping an eye on. After all, the future belongs to those who shape it—and MetAlert seems to be holding the chisel.
Remember, investing is not merely about watching numbers grow—it’s about being part of stories that matter, and MetAlert’s tale is one that could redefine healthcare as we know it.
Stay tuned with us as we continue to bring you the latest from the financial world, keeping you at the vanguard of investment opportunities.
Disclaimer: This article does not provide financial advice. Always do your own research and consult with a professional before making financial decisions.
Read original article: https://pubcoinsight.com/riding-the-cutting-edge-why-metalert-deserves-your-attention/
MetAlert
@metalertinc
·
1h
Experience the future of healthcare with MetAlert's AI virtual health assistant. Get professional care at the touch of a button, without the traditional costs and inconvenience. Visit http://metalert.com/hands-free-tele-health for more info #SmartCare $MLRT #Knowledgeishealth #Telehealth #AI #Care
MLRT now part of Walmart healthcare system
This telehealth partnership opens them up to all customers who use Walmart. I see more and more big brand stores moving into healthcare services to compete with likes of Walgreen's and CVS, and Walmart has a huge customer user base.
.15 key breakout trigger
Do you really think so?
.15 up
This train is leaving station, and still hasn't hit radars yet
Maybe you should have average down....
That’s Huge news$$$$
Bid moving up, her we go...ready to pop!
Breaking early April high and could see this quickly run to .20+ here
Walmart urgent healthcare services
100% Agreeeee outstanding shares nothing extremely low and L2 way toooo thin$$$$
Followers
|
138
|
Posters
|
|
Posts (Today)
|
4
|
Posts (Total)
|
9452
|
Created
|
03/18/08
|
Type
|
Free
|
Moderators |
MetAlert is a pioneer in smart, mobile, and wearable GPS tracking and recovery location-based solutions designed around health and safety. Supported through a proprietary IoT enterprise monitoring platform and intellectual property portfolio, MetAlert offers a global end-to-end solution of hardware, software, and connectivity, and develops tracking technologies, which seamlessly integrate with consumer products and enterprise applications. MetAlert is known for its game-changing and award-winning patented GPS SmartSole® — think Dr. Scholl’s meets LoJack, the world’s first invisible wearable technology tracking device created for those at risk of wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. MetAlert products utilize the latest in miniaturized, low-power consumption GPS, Cellular, RF, NFC, and BLE technology, enabling subscribers to track in real time the whereabouts of people or high-value assets. MetAlert is also in the protective medical supply business and has developed innovative technology-driven solutions. The company has customers in all 50 States and international distributors servicing customers in over 35 countries. The Company’s customers range from the U.S. Military, Foreign Military, public health authorities and municipalities, emergency, and law enforcement, first responders, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes, and direct-to-consumer.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |